查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566963

蝦青素市場：按來源、形式和應用分類：2024-2033 年全球機會分析和產業預測

Astaxanthin Market By Source (Natural, Synthetic) , By Form (Dry, Liquid) By Application (Dietary supplements, Cosmetics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

蝦蝦青素市場

2023年蝦青素市值為8億美元，預計2024年至2033年複合年成長率為8.1%，到2033年將達16億美元。

蝦青素是一種紅色素，屬於葉黃素類胡蘿蔔素類別，存在於多種微生物和海洋生物中。蝦青素以其抗氧化特性而聞名，並能保護細胞免受自由基的侵害。這種化合物以補充品的形式食用，可以促進大腦、眼睛和皮膚健康，調節高膽固醇水平，並支持免疫系統。此外，蝦青素也用於水產養殖業，將色素添加到養殖的鱒魚、鮭魚和蝦中。這個過程改善了水產養殖產品的外觀並增加了其市場規模。

人們對健康生活方式和膳食食品重要性的認知不斷提高，是蝦青素市場的關鍵促進因素。此外，由於蝦青素是一種天然產品，由於人們對有機或天然產品的青睞激增，補充品和化妝品行業對蝦紅素的需求量很大。未來，在作物生產中利用蝦青素的趨勢預計將獲得巨大的推動力。根據科學組合 SpringerLink 發表的一篇論文，將蝦青素應用於水稻幼苗可以消除氧化壓力，調節體內平衡，並提高耐鹽性。

然而，高劑量蝦青素引起的消化器官系統疾病等副作用的潛在風險阻止了一些人的消費並阻礙了市場成長。此外，從自然資源中提取蝦青素正逐漸導致微藻類和其他海洋生物的消耗。這一因素阻礙了蝦青素在多種應用中的使用。相反，為了應對資源枯竭的挑戰，世界各地成立了多家微藻類生產公司，將蝦青素生產轉移到實驗室。截至2022年9月，歐盟委員會已認定歐洲17個國家的87家公司。這些公司使用反應器來培養產生蝦青素的微藻類。從這些培養的微藻類中提取蝦青素具有多種優點，例如減少環境污染、可擴展性機會以及減少自然資源的開採。

分部審查

蝦青素市場分為來源、形式、應用和地區。根據來源，市場分為天然和合成。依形態的不同，可分為乾燥的和液體的。依用途分為營養食品、化妝品等。從區域來看，分析包括北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

從來源來看，天然細分市場在 2023 年佔據主導地位。

從業態來看，乾燥區隔市場將在 2023 年佔據較高的市場。

從應用來看，到 2033 年，食品領域預計將佔高比例。

按地區分類，北美地區 2023 年收益最高。

可以使用此報告進行客製化（需要額外費用和時間表）

  • 國家、區域和全球各級的患者/流行病學資料
  • 監管指引
  • 針對客戶興趣的其他公司簡介
  • 擴大公司簡介列表
  • 歷史市場資料
  • SWOT分析

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章蝦青素市場：依來源分類

  • 市場概況
  • 自然的
  • 合成

第5章蝦青素市場：依形式

  • 市場概況
  • 乾法
  • 液體

第6章蝦青素市場：依應用分類

  • 市場概況
  • 食品補充品
  • 化妝品
  • 其他

第7章蝦青素市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國蝦青素市場
    • 加拿大蝦蝦青素市場
    • 墨西哥蝦蝦青素市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國蝦蝦青素市場
    • 德國蝦蝦青素市場
    • 義大利蝦蝦青素市場
    • 西班牙蝦蝦青素市場
    • 英國蝦青素市場
    • 其他歐洲蝦蝦青素市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國蝦青素市場
    • 日本蝦蝦青素市場
    • 印度蝦蝦青素市場
    • 韓國蝦蝦青素市場
    • 澳洲蝦青素市場
    • 其他亞太地區蝦蝦青素市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西蝦蝦青素市場
    • 南非蝦蝦青素市場
    • 沙烏地阿拉伯蝦蝦青素市場
    • 其他拉丁美洲/中東/非洲蝦蝦青素市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • INNOBIO Limited
  • Divis Laboratories Limited
  • Algaecan Biotech
  • ALGA Technologies
  • Cyanotech Corporation.
  • Otsuka Pharmaceutical Co.
  • Cardax
  • Fenchem
  • BGG
  • Fuji Chemical Industries Company Limited
簡介目錄
Product Code: A324369

Astaxanthin Market

The astaxanthin market was valued at $0.8 billion in 2023 and is projected to reach $1.6 billion by 2033, growing at a CAGR of 8.1% from 2024 to 2033.

Astaxanthin is a red-colored pigment that belongs to the category of xanthophyll carotenoid and is present in several microorganisms and marine organisms. Astaxanthin is known for its antioxidant properties and aids in the protection of cells from free radicals. The compound is consumed in the form of supplements to enhance the health of brain, eyes, & skin; regulate high cholesterol levels; and support the immune system. Moreover, astaxanthin is used in the aquaculture industry to integrate pigmentation into farmed trout, salmons, and shrimps. This process elevates the appearance of aquaculture products and enhances their market value.

Increase in awareness regarding fit lifestyle and importance of health supplements is a significant driver of the astaxanthin market. In addition, astaxanthin is a natural product due to which it witnesses a high demand from the supplements and cosmetics industries, owing to surge in inclination toward organic or natural products. In the coming future, the trend of utilizing astaxanthin in crop production is anticipated to acquire notable traction. As per an article published by SpringerLink, a scientific portfolio, application of astaxanthin into rice seedlings eliminates their oxidative stress, regulates their homeostatic balance, and boosts their tolerance toward salinity.

However, the potential risk of side effects, such as disturbances in digestive system, due to high dosage of astaxanthin deters several individuals from its consumption and hampers the growth of the market. Furthermore, the extraction of astaxanthin from natural resources is gradually resulting in the depletion of microalgae and other marine organisms. This factor discourages the use of astaxanthin in diverse applications. Contrarily, to address the challenge of resource depletion, several microalgae-producing enterprises have been established across the globe to shift the production of astaxanthin into laboratories. As of September 2022, the European Commission identified 87 enterprises in 17 countries of Europe. These enterprises cultivate the astaxanthin-producing microalgae using photobioreactors. The extraction of astaxanthin from these cultured microalgae offers several benefits such as decreased environmental pollution, availability of scalability opportunities, and reduced exploitation of natural resources.

Segment Review

The astaxanthin market is divided into source, form, application, and region. On the basis of source, the market is bifurcated into natural and synthetic. As per form, it is divided into dry and liquid. Depending on application, it is classified into dietary supplements, cosmetics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of source, the natural segment dominated the market in 2023.

As per form, the dry segment acquired a high stake in the market in 2023.

Depending on application, the dietary supplements segment is projected to account for a high share of the market by 2033.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The key players operating in the global astaxanthin market include INNOBIO Limited, Divis Laboratories Limited, Algaecan Biotech, ALGA Technologies, Cyanotech Corporation., Otsuka Pharmaceutical Co., Cardax, Fenchem, BGG, and Fuji Chemical Industries Company Limited. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Source

  • Natural
  • Synthetic

By Form

  • Dry
  • Liquid

By Application

  • Dietary supplements
  • Cosmetics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • INNOBIO Limited
    • Divis Laboratories Limited
    • Algaecan Biotech
    • ALGA Technologies
    • Cyanotech Corporation.
    • Otsuka Pharmaceutical Co.
    • Cardax
    • Fenchem
    • BGG
    • Fuji Chemical Industries Company Limited

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ASTAXANTHIN MARKET, BY SOURCE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Source
  • 4.2. Natural
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Synthetic
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ASTAXANTHIN MARKET, BY FORM

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Form
  • 5.2. Dry
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Liquid
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: ASTAXANTHIN MARKET, BY APPLICATION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Application
  • 6.2. Dietary Supplements
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Cosmetics
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: ASTAXANTHIN MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Source
    • 7.2.3. Market Size and Forecast, By Form
    • 7.2.4. Market Size and Forecast, By Application
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Astaxanthin Market
      • 7.2.6.1. Market Size and Forecast, By Source
      • 7.2.6.2. Market Size and Forecast, By Form
      • 7.2.6.3. Market Size and Forecast, By Application
    • 7.2.7. Canada Astaxanthin Market
      • 7.2.7.1. Market Size and Forecast, By Source
      • 7.2.7.2. Market Size and Forecast, By Form
      • 7.2.7.3. Market Size and Forecast, By Application
    • 7.2.8. Mexico Astaxanthin Market
      • 7.2.8.1. Market Size and Forecast, By Source
      • 7.2.8.2. Market Size and Forecast, By Form
      • 7.2.8.3. Market Size and Forecast, By Application
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Source
    • 7.3.3. Market Size and Forecast, By Form
    • 7.3.4. Market Size and Forecast, By Application
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Astaxanthin Market
      • 7.3.6.1. Market Size and Forecast, By Source
      • 7.3.6.2. Market Size and Forecast, By Form
      • 7.3.6.3. Market Size and Forecast, By Application
    • 7.3.7. Germany Astaxanthin Market
      • 7.3.7.1. Market Size and Forecast, By Source
      • 7.3.7.2. Market Size and Forecast, By Form
      • 7.3.7.3. Market Size and Forecast, By Application
    • 7.3.8. Italy Astaxanthin Market
      • 7.3.8.1. Market Size and Forecast, By Source
      • 7.3.8.2. Market Size and Forecast, By Form
      • 7.3.8.3. Market Size and Forecast, By Application
    • 7.3.9. Spain Astaxanthin Market
      • 7.3.9.1. Market Size and Forecast, By Source
      • 7.3.9.2. Market Size and Forecast, By Form
      • 7.3.9.3. Market Size and Forecast, By Application
    • 7.3.10. UK Astaxanthin Market
      • 7.3.10.1. Market Size and Forecast, By Source
      • 7.3.10.2. Market Size and Forecast, By Form
      • 7.3.10.3. Market Size and Forecast, By Application
    • 7.3.11. Rest of Europe Astaxanthin Market
      • 7.3.11.1. Market Size and Forecast, By Source
      • 7.3.11.2. Market Size and Forecast, By Form
      • 7.3.11.3. Market Size and Forecast, By Application
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Source
    • 7.4.3. Market Size and Forecast, By Form
    • 7.4.4. Market Size and Forecast, By Application
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Astaxanthin Market
      • 7.4.6.1. Market Size and Forecast, By Source
      • 7.4.6.2. Market Size and Forecast, By Form
      • 7.4.6.3. Market Size and Forecast, By Application
    • 7.4.7. Japan Astaxanthin Market
      • 7.4.7.1. Market Size and Forecast, By Source
      • 7.4.7.2. Market Size and Forecast, By Form
      • 7.4.7.3. Market Size and Forecast, By Application
    • 7.4.8. India Astaxanthin Market
      • 7.4.8.1. Market Size and Forecast, By Source
      • 7.4.8.2. Market Size and Forecast, By Form
      • 7.4.8.3. Market Size and Forecast, By Application
    • 7.4.9. South Korea Astaxanthin Market
      • 7.4.9.1. Market Size and Forecast, By Source
      • 7.4.9.2. Market Size and Forecast, By Form
      • 7.4.9.3. Market Size and Forecast, By Application
    • 7.4.10. Australia Astaxanthin Market
      • 7.4.10.1. Market Size and Forecast, By Source
      • 7.4.10.2. Market Size and Forecast, By Form
      • 7.4.10.3. Market Size and Forecast, By Application
    • 7.4.11. Rest of Asia-Pacific Astaxanthin Market
      • 7.4.11.1. Market Size and Forecast, By Source
      • 7.4.11.2. Market Size and Forecast, By Form
      • 7.4.11.3. Market Size and Forecast, By Application
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Source
    • 7.5.3. Market Size and Forecast, By Form
    • 7.5.4. Market Size and Forecast, By Application
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Astaxanthin Market
      • 7.5.6.1. Market Size and Forecast, By Source
      • 7.5.6.2. Market Size and Forecast, By Form
      • 7.5.6.3. Market Size and Forecast, By Application
    • 7.5.7. South Africa Astaxanthin Market
      • 7.5.7.1. Market Size and Forecast, By Source
      • 7.5.7.2. Market Size and Forecast, By Form
      • 7.5.7.3. Market Size and Forecast, By Application
    • 7.5.8. Saudi Arabia Astaxanthin Market
      • 7.5.8.1. Market Size and Forecast, By Source
      • 7.5.8.2. Market Size and Forecast, By Form
      • 7.5.8.3. Market Size and Forecast, By Application
    • 7.5.9. Rest of LAMEA Astaxanthin Market
      • 7.5.9.1. Market Size and Forecast, By Source
      • 7.5.9.2. Market Size and Forecast, By Form
      • 7.5.9.3. Market Size and Forecast, By Application

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. INNOBIO Limited
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Divis Laboratories Limited
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Algaecan Biotech
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. ALGA Technologies
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Cyanotech Corporation.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Otsuka Pharmaceutical Co.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Cardax
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Fenchem
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. BGG
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Fuji Chemical Industries Company Limited
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments